ORLANDO, Fla. – At the 17th annual Society for Biomolecular Sciences 2011 conference in Orlando, Florida, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, will be showcasing several new drug discovery technologies and applications. The PerkinElmer exhibit, located at Booth 701, will include new products based on […]
Boulder, Colorado. BiOptix Diagnostics, Inc., a Boulder, CO based analytical instrumentation firm, announced today the closing of $9M Series B financing. The $9M round was led by The Russian Corporation for Nanotechnologies (“RUSNANO”) which was joined in the round by Boulder Ventures Ltd., Peierls Foundation, and several private investors. “RUSNANO has collaborated with high technology […]
TORONTO – The Ontario Institute for Cancer Research (OICR) announced today it has made an investment to accelerate commercialization of a potentially revolutionary high-throughput screening technology directed at the discovery of anticancer drugs. The technology, Smart Well Plate™, developed at the University of Toronto, is a palm-sized device that utilizes digital microfluidics (DMF), a technique […]
TUCSON, Ariz. – HTG, Inc., provider of molecular technology solutions, today announced it has officially changed its name to HTG Molecular Diagnostics. The company, formerly known as High Throughput Genomics or HTG, made the change to convey the company’s strategic vision and direction in providing molecular testing capabilities for clinical researchers, pharmaceutical clinical development and […]
RUSNANO has invested $4.5 million dollars in a project to expand production of label-free biodetectors and bionanoslides with their American developer, BiOptix Diagnostics, Inc. Two American venture capital funds, Boulder Ventures, Ltd. and Peierls Foundation, and private investors have invested another $4.5 million in authorized capital of BiOptix. The project, which has a total budget […]
BILLERICA, Mass. – EMD Millipore, the Life Science division of Merck KGaA of Germany, today announced plans to expand its industrial microbiological testing portfolio. This follows Merck KGaA‘s announcement it has entered into a definitive agreement to acquire the microbiology business of Germany-based Biotest AG. The acquisition will strengthen EMD Millipore’s Biomonitoring business, further enhancing […]
Darmstadt, Germany – Merck KGaA announced today that it has entered into a definitive agreement to acquire the microbiology business of Biotest AG, Dreieich, Germany. This business comprises heipha Dr. Müller GmbH, located in Eppelheim, Germany, as well as the Hycon business located in Dreieich, the subsidiaries in France, Japan and in the USA as […]
Royston, UK – Dolomite, a world leader in microfluidic design and manufacture, has introduced a new range of Small Droplet Chips, glass microfluidic devices which can be used with the Droplet Advanced System to generate highly monodispersed micro-droplets. Ideal for producing and analysing microemulsions, the innovative Small Droplet Chips are currently the smallest commercial droplet-making […]
Fluidigm has announced that MLL Munich Leukemia Laboratory (www.mll.com) has used the company’s Access Array™ technology to help it uncover mutations in over 80 percent of chronic myelomonocytic leukemia (CMML) patients, providing new insights into the molecular heterogeneity of the disease. MLL researchers applied the unique properties of the Fluidigm Access Array System to prepare […]
Brussels – PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today the launch of three new methods for coupling proteins to the gold nanoparticles used with PharmaDiagnostics’ SoPRanoTM technology. The new coupling methods will greatly expand the technology’s applicability in the key drug […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
